Cambridge Healthtech Institute’s 21st Annual

Target Identification Strategies

Effective Use of Chemoproteomics, Functional Genomics, and AI/ML for Target Discovery

October 2-3, 2024

 

Along with finding novel targets for therapeutic intervention, identifying and validating them to be "druggable" remains a top priority for the pharma/biotech industry. Cambridge Healthtech Institute’s conference on Target Identification Strategies focuses on the use of chemical biology, proteomics, cell-based assays, CRISPR screening, single-cell sequencing, spatial analysis, and other innovative approaches for studying target engagement and deconvolution. Case studies highlight how complementary use of genomic and proteomic technologies along with artificial intelligence (AI), machine learning (ML), imaging, and 3D organoids are being used to study cellular pathways and pursue difficult or “undruggable” targets for drug discovery.

 

Who should attend: Scientist, Team Leader, Vice President, CSO, CEO in Biology, Chemistry, Target Discovery, Disease Modeling, Proteomics, Genomics, Screening and Assay Development

 

Coverage will include, but is not limited to:

 

  • Chemoproteomic and induced proximity-based strategies for target ID and validation
  • Label-free, mass spectrometry, activity-based protein profiling, and other screening approaches
  • Emerging biophysical, imaging, and cellular assays for target engagement and deconvolution
  • Phenotypic versus target-based screening approaches
  • Functional genomics and chemical genetics for in vitro and in vivo target screening
  • Use of single-cell sequencing, spatial biology, and transcriptome analysis for drug discovery
  • CRISPR and other functional genomics-based screening for finding novel targets
  • Microscopy-based tools like cell painting for genomic and spatial studies of target biology
  • 3D organoid models for disease modeling and target discovery
  • Using AI/ML to identify, evaluate, and prioritize drug targets

 

The deadline for priority consideration is March 8, 2024.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 

 

For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com

 

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com